Funding Resources
Funding Overview
Funding Strategy
Funding Opportunities |
Research
Anticonvulsant Screening
Program
Clinical Research
Counterterrorism
Epilepsy Research Web
Neural Interfaces Program
NIH Roadmap Research
Parkinson's Web
Resources for Scientists
Stem Cell Research
Translational Research
Traumatic Brain Injury
(TBI) Research
Technology Transfer
Office
NINDS is part of the
National Institutes of
Health
Application processes at NIH are changing. Applicant organizations are encouraged to start preparing for this transition by registering with Grants.gov and NIH eRA Commons now. |
Basic and Clinical Research on Rett Syndrome and MECP2 (R21)
Release Date: March 24, 2006
Announcement Number: PAS-06-274
Application Receipt Date:
June 1, 2006
October 1, 2006
February 16, 2007
June 16, 2007
October 16, 2007
Funding Contact: Laura Mamounas, Ph.D.
Program Area: Neurogenetics
Brief Description:
The National Institute of Neurological Disorders and Stroke (NINDS), the National Institute of Child Health and Human Development
(NICHD), the National Institute of Mental Health (NIMH), the International Rett Syndrome Association (IRSA) and the Rett Syndrome
Research Foundation (RSRF) invite research grant applications aimed at understanding and/or treating Rett Syndrome (RTT).
The recent demonstration that mutations in the MECP2 gene cause most cases of RTT has created new opportunities for both basic
and clinical research. Included within the scope of this funding opportunity announcement (FOA) with set-aside funds are developmental,
neuroanatomical, molecular genetic, and pathophysiological research, therapy development projects and clinical studies. Studies
of the role of MeCP2 in basic biological processes or in the etiology of other neurological or neurobehavioral disorders are
also appropriate.
Choose an option to view additional funding announcements |
New Announcements | Research Area | RFAs Only | PAs Only | RFPs Only | Notices Only | Supplements Only | All Announcements | Archives |